Literature DB >> 32146819

Guidelines for biliary stents and drains.

Lorraine C Drapek1, Robert K Kerlan2, Susan Acquisto3.   

Abstract

Hepatobiliary and pancreatic cancers can cause malignant biliary constriction of the bile ducts, a lethal complication that leads to obstruction of the bile ducts, cholangitis, sepsis, and death. Patients may present with symptoms such as painless jaundice, dark or amber urine, light colored stools, and weight loss. These patients often have locally advanced disease at presentation, and surgical intervention is often not possible. Biliary stents or percutaneous transhepatic drains are often the treatment intervention to relieve biliary obstruction. This is a perspective educational paper providing an in-depth discussion on management strategies, care of the patient by oncology health providers, and important education for the patient and family.

Entities:  

Keywords:  Biliary obstruction; cholangitis; percutaneous transhepatic biliary drainage; self-expandable metallic stents

Year:  2020        PMID: 32146819     DOI: 10.21037/cco.2020.02.01

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  3 in total

1.  The implications and management of complex biliary injuries at a tertiary hepatobiliary specialty center.

Authors:  Rasha T Kakati; Mohamad Othman; Hussein Kharroubi; Karim Ataya; Hussein Nassar; Bassel Hafez; Walid Faraj; Mohamad Jawad Khalife
Journal:  SAGE Open Med Case Rep       Date:  2022-08-24

Review 2.  Surgical Treatment of Distal Cholangiocarcinoma.

Authors:  Leva Gorji; Eliza W Beal
Journal:  Curr Oncol       Date:  2022-09-17       Impact factor: 3.109

3.  Endoscopic retrograde cholangiopancreatography drainage for palliation of malignant hilar biliary obstruction - stent-in-stent or side-by-side? A systematic review and meta-analysis.

Authors:  Gabriel Mayo Vieira de Souza; Igor Braga Ribeiro; Mateus Pereira Funari; Diogo Turiani Hourneaux de Moura; Maria Vitória Cury Vieira Scatimburgo; João Remí de Freitas Júnior; Sergio A Sánchez-Luna; Renato Baracat; Eduardo Turiani Hourneaux de Moura; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura
Journal:  World J Hepatol       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.